1998
DOI: 10.1086/515032
|View full text |Cite
|
Sign up to set email alerts
|

Interleukin‐10: Potential Benefits and Possible Risks in Clinical Infectious Diseases

Abstract: Human interleukin-10 (IL-10) is a potent anti-inflammatory cytokine that inhibits the synthesis of the major proinflammatory cytokines and chemokines. IL-10 is the principal TH2-type cytokine that upregulates humoral immune responses and attenuates cell-mediated immune reactions. This cytokine has a number of immunomodulatory properties that might be clinically useful in a variety of inflammatory and infectious disease states. Clinical trials with human recombinant IL-10 are already in progress. Carefully sele… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

4
59
2
10

Year Published

2000
2000
2013
2013

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 102 publications
(75 citation statements)
references
References 87 publications
4
59
2
10
Order By: Relevance
“…23 Prematurely downregulated Th1 activity by IL-10 and other anti-inflammatory factors can lead to persistent C trachomatis infection where the presence of infectious organisms maintain continuous inflammation leading to tissue damage. 24 Especially genital strains of C trachomatis have adapted to host IFN-g-mediated defence mechanisms by developing genetically regulated means to replace IFN-g-induced tryptophane depletion. 25 Moreover, concomitant infection with another Th2 activating microorganism, 26 preexistence of microenvironmental cytokines, 27 or hormonal status of the host 28 may compromise Th1 activation following C trachomatis infection.…”
Section: Discussionmentioning
confidence: 99%
“…23 Prematurely downregulated Th1 activity by IL-10 and other anti-inflammatory factors can lead to persistent C trachomatis infection where the presence of infectious organisms maintain continuous inflammation leading to tissue damage. 24 Especially genital strains of C trachomatis have adapted to host IFN-g-mediated defence mechanisms by developing genetically regulated means to replace IFN-g-induced tryptophane depletion. 25 Moreover, concomitant infection with another Th2 activating microorganism, 26 preexistence of microenvironmental cytokines, 27 or hormonal status of the host 28 may compromise Th1 activation following C trachomatis infection.…”
Section: Discussionmentioning
confidence: 99%
“…The mechanisms involved in the improved clearance of bacteria from the peritoneal cavity of IL-10 Ϫ/Ϫ mice remain to be established. IL-10 may exert direct anti-inflammatory effects on cells involved in host defense against bacteria, i.e., IL-10 can decrease neutrophil degranulation and chemotaxis, and can suppress oxygen radical and NO synthesis (21). The net effect of the increased influx of neutrophils in peritoneal fluid of IL-10 Ϫ/Ϫ mice, likely at least in part mediated by locally elevated concentrations of the CXC chemokines MIP-2 and KC (45,46), is uncertain.…”
Section: Discussionmentioning
confidence: 99%
“…IL-10 is an 18-kDa cytokine produced under different conditions of immune activation by a variety of cell types, including T cells, B cells, monocytes, and macrophages (20,21). IL-10 is considered a prototypic anti-inflammatory cytokine and potently inhibits the production of proinflammatory cytokines in vitro and in vivo (22)(23)(24)(25)(26).…”
Section: Il-10-deficient Mice Demonstrate Multiple Organ Failure and mentioning
confidence: 99%
“…[16][17][18][19][20][21][22] However, the role of IL-10 in renal tubulointerstitial fibrosis has not been studied. Here, we used IL-10 À / À mice [23][24][25][26] with unilateral ureteral obstruction (UUO), a well-established model for kidney fibrosis, to investigate the roles of IL-10 in the progression of renal fibrosis.…”
mentioning
confidence: 99%